A detailed history of Joel Isaacson & Co., LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Joel Isaacson & Co., LLC holds 3,323 shares of REGN stock, worth $2.37 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
3,323
Previous 3,323 -0.0%
Holding current value
$2.37 Million
Previous $3.49 Million 0.03%
% of portfolio
0.17%
Previous 0.18%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

BUY
$883.2 - $1071.19 $21,196 - $25,708
24 Added 0.73%
3,323 $3.49 Million
Q1 2024

Apr 29, 2024

BUY
$902.69 - $993.35 $1,805 - $1,986
2 Added 0.06%
3,299 $3.18 Million
Q4 2023

Jan 24, 2024

BUY
$775.18 - $881.7 $24,030 - $27,332
31 Added 0.95%
3,297 $2.9 Million
Q3 2023

Oct 23, 2023

BUY
$692.45 - $844.37 $26,313 - $32,086
38 Added 1.18%
3,266 $2.69 Million
Q1 2023

Apr 24, 2023

SELL
$680.49 - $826.97 $17,012 - $20,674
-25 Reduced 0.77%
3,228 $2.65 Million
Q4 2022

Jan 27, 2023

BUY
$705.89 - $766.39 $9,882 - $10,729
14 Added 0.43%
3,253 $0
Q3 2022

Oct 13, 2022

SELL
$573.97 - $724.32 $1,147 - $1,448
-2 Reduced 0.06%
3,239 $2.23 Million
Q2 2022

Jul 15, 2022

SELL
$548.35 - $738.84 $2,741 - $3,694
-5 Reduced 0.15%
3,241 $1.92 Million
Q1 2022

Apr 21, 2022

SELL
$595.12 - $698.43 $3,570 - $4,190
-6 Reduced 0.18%
3,246 $2.35 Million
Q4 2021

Jan 19, 2022

BUY
$543.48 - $670.97 $3,260 - $4,025
6 Added 0.18%
3,252 $2.05 Million
Q2 2021

Jul 20, 2021

SELL
$472.8 - $558.54 $472 - $558
-1 Reduced 0.03%
3,246 $1.81 Million
Q3 2020

Oct 14, 2020

BUY
$544.75 - $658.21 $4,902 - $5,923
9 Added 0.28%
3,247 $1.82 Million
Q2 2020

Jul 21, 2020

BUY
$493.32 - $643.92 $111,490 - $145,525
226 Added 7.5%
3,238 $2.02 Million
Q1 2020

Apr 21, 2020

BUY
$336.18 - $494.43 $4,034 - $5,933
12 Added 0.4%
3,012 $1.47 Million
Q3 2019

Oct 15, 2019

SELL
$273.46 - $318.39 $7,656 - $8,914
-28 Reduced 0.92%
3,000 $832,000
Q2 2019

Jul 11, 2019

SELL
$299.6 - $414.82 $4,194 - $5,807
-14 Reduced 0.46%
3,028 $948,000
Q1 2019

Apr 09, 2019

BUY
$372.08 - $439.57 $9,302 - $10,989
25 Added 0.83%
3,042 $1.25 Million
Q4 2018

Jan 18, 2019

BUY
$335.82 - $403.04 $5,708 - $6,851
17 Added 0.57%
3,017 $1.23 Million
Q2 2018

Aug 01, 2018

SELL
$284.6 - $344.99 $3,415 - $4,139
-12 Reduced 0.4%
3,000 $1.04 Million
Q1 2018

May 01, 2018

BUY
$315.82 - $393.78 $3,789 - $4,725
12 Added 0.4%
3,012 $1.04 Million
Q3 2017

Nov 02, 2017

BUY
$431.38 - $504.0 $1.29 Million - $1.51 Million
3,000
3,000 $1.34 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Joel Isaacson & Co., LLC Portfolio

Follow Joel Isaacson & Co., LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Joel Isaacson & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Joel Isaacson & Co., LLC with notifications on news.